MediVision reduces hold on Ophthalmic Imaging Systems:
This article was originally published in Clinica
MediVision Medical Imaging has further reduced its stake in Ophthalmic Imaging Systems (OIS) following the sale of 500,000 shares of common stock, priced at $1.38 each. The Yokneam, Israel company now has a 75% share in Sacramento, California-based OIS.
You may also be interested in...
Resolution Medical teamed up with Carbon to introduce more than one million 3D-printed nasal swabs a week to address the shortage for COVID-19 testing.
Early results from the Low-Risk Bicuspid study of the Evolut transcatheter aortic valve replacement system showed low rates of all-cause mortality or stroke.
The reality is that many trials requiring hospital based tests and interventions cannot be replaced, but crisis will spur take up where practical.